Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Government In Dilemma As DCGI's Competence Is Questioned Amid Mounting Criticism

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - An eerie uncertainty looms over the future of India's highest and most powerful drug authority, the Drug Controller General of India, as the government was challenged last week against its decision to grant a nine-month service term extension to the present incumbent Surinder Singh
Advertisement

Related Content

Graft Charges At India State Drug Controller’s Office Lead To Multiple Transfers
Powerful Parliamentary Committee Slams India’s Drug Regulator; Calls For Swift Overhaul
R&D Funding, Epidemiology And Balanced Policies To Fuel India Growth - CII Lifescience Conclave
R&D Funding, Epidemiology And Balanced Policies To Fuel India Growth - CII Lifescience Conclave
Launching Clinical Trials In India? Beware Of Long Delays And New Mandates
India's Drug Controller Trapped In Crossfire Of Rival Lobbying Groups
Drug Controller General Of India Surinder Singh On India’s Regulatory Overhaul: An Interview With PharmAsia News
Drug Controller General Of India Surinder Singh On India’s Regulatory Overhaul: An Interview With PharmAsia News
Advertisement
UsernamePublicRestriction

Register

SC078594

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel